abstract |
The present invention is directed to tumor necrosis factor-alpha (TNF-alpha or TNF-α) inhibitory peptides and procedures for their preparation. The invention further relates to pharmaceutical compositions comprising the TNF-alpha inhibitory peptides of the invention and their use in the treatment of TNF-alpha mediated inflammatory disorders. |